cardiovascular system
• dilatation and narrowing at P42
|
growth/size/body
weight loss
(
J:286022
)
• starting at P28
|
• starting at P28
|
homeostasis/metabolism
• progressive, starting around P28
|
immune system
• eosinophilic material in some proximal and distal tubules at P28
|
mortality/aging
• between postnatal weeks 6 and 8
|
renal/urinary system
• dilatation and narrowing at P42
|
• at P42, mice exhibit mesangial cell expansion and activation in the smooth muscle cell of blood vessels, the center of the glomerular tufts (P57), and in Bowmans capsule (P42 and P57) unlike control mice
|
• progressive, starting around P28
|
• eosinophilic material in some proximal and distal tubules at P28
|
• at P42
|
• resulting in podocyte fusion, complete loss of slit diaphragm and microvillous transformation at P42
|
• with reduction in mature slit diaphragm at P28
|
• at P42
|
• at P42
|
• at P42
|
• at P42
|
• focal segmental glomerulosclerosis (FSGS) with some glomeruli severely affected while others have no signs of pathology
• however, mice do not exhibit endothelial fenestration or altered glomeruli basement membrane morphology
|
• of glomerular tufts to Bowmans capsule with dilation of both at P42
|
• increased collagen deposition at P42
|
• reduced glomerular filtration rate at P28
|
cellular
• at P42, mice exhibit mesangial cell expansion and activation in the smooth muscle cell of blood vessels, the center of the glomerular tufts (P57), and in Bowmans capsule (P42 and P57) unlike control mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
focal segmental glomerulosclerosis | DOID:1312 |
OMIM:PS603278 |
J:286022 |